{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:16:13Z","timestamp":1757618173839,"version":"3.44.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Urine drug testing (UDT) is recommended, yet underutilized, for patients receiving opioids for cancer pain. The primary aim of this study was to evaluate the impact of an embedded onco-palliative care clinic on UDT among patients with lung cancer. The number of patients tested, the timing of the first UDT, the incidence of unexplained UDT results, testing frequency, and substances detected on UDT were explored.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This is a single-institution retrospective study of patients diagnosed with any stage thoracic malignancy who began urine drug testing 1\u00a0year before (pre-cohort) and 1\u00a0year after (post-cohort) implementation of an embedded thoracic oncology-palliative care clinic in Columbus, Ohio, USA, on September 5, 2018. Confirmatory UDT was routinely ordered for any patient receiving opioids prescribed by palliative care or via ad hoc testing by oncology providers regardless of palliative care referral status.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>More patients completed UDT after implementation of an embedded onco-palliative care clinic (pre-cohort, <jats:italic>n<\/jats:italic>\u2009=\u200961; post-cohort, <jats:italic>n<\/jats:italic>\u2009=\u2009182). Pre-cohort patients began UDT closer to death with median survival of 5.2\u00a0months after first UDT (post-cohort, 10.9\u00a0months; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). While a larger proportion of post-cohort patients completed\u2009&gt;\u20091 UDT (pre, 26.6%, post, 46.7%; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01), there was no significant difference in the proportion of patients experiencing an unexplained UDT result (pre, 9.8% vs. post, 11.0%, <jats:italic>p<\/jats:italic>\u2009=\u20090.80).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Implementation of an embedded onco-palliative care clinic was associated with a significant increase in use and earlier initiation of UDT among patients receiving care in a thoracic oncology clinic.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00520-025-09622-3","type":"journal-article","created":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T19:20:52Z","timestamp":1750015252000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of an embedded onco-palliative care clinic on urine drug testing in thoracic oncology"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9967-0818","authenticated-orcid":false,"given":"Julia L.","family":"Agne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda V.","family":"Gusovsky Chevalier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason A.","family":"Benedict","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nida","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Saphire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madison M.","family":"Grogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin","family":"Kullgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin S.","family":"Kale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann Scheck","family":"McAlearney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolyn J.","family":"Presley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"issue":"9784","key":"9622_CR1","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/S0140-6736(11)60236-5","volume":"377","author":"RK Portenoy","year":"2011","unstructured":"Portenoy RK (2011) Treatment of cancer pain. Lancet 377(9784):2236\u20132247","journal-title":"Lancet"},{"issue":"2","key":"9622_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.pmr.2014.01.013","volume":"25","author":"B Kahan","year":"2014","unstructured":"Kahan B (2014) Cancer pain and current theory for pain control. Phys Med Rehabil Clin N Am 25(2):439\u2013456","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"9622_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.genhosppsych.2019.04.016","volume":"60","author":"M Yusufov","year":"2019","unstructured":"Yusufov M, Braun IM, Pirl WF (2019) A systematic review of substance use and substance use disorders in patients with cancer. Gen Hosp Psychiatry 60:128\u2013136","journal-title":"Gen Hosp Psychiatry"},{"key":"9622_CR4","doi-asserted-by":"crossref","unstructured":"Swarm RA, Y.J., Agne JL, Anitescu M, Are M, Buga S, Chwistek M, Cleary J, Copenhaver D, Coyne C, Craig D, Finnes H, Greenlee H, Gupta M, Hansen E, Javed S, Kamdar MM, Kandil E, Mackey S, McDonald A, McGrath K, Moryl N, Nesbit S, Norris J, Paice JA, Poe L, Prsic E, Rabow MW, Rickerson E, Sag A, Sindt J, Smith M, Vorenkamp K, Yang Bruce J, Yoo S, Gurski LA, Jones F, NCCN clinical practice guidelines in oncology (NCCN Guidelines\u00ae) for Adult Cancer Pain v1.2024. 2024","DOI":"10.6004\/jnccn.2025.0032"},{"issue":"10","key":"9622_CR5","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1634\/theoncologist.2019-0301","volume":"24","author":"JA Paice","year":"2019","unstructured":"Paice JA (2019) Risk assessment and monitoring of patients with cancer receiving opioid therapy. Oncologist 24(10):1294\u20131298","journal-title":"Oncologist"},{"issue":"6","key":"9622_CR6","doi-asserted-by":"publisher","first-page":"e687","DOI":"10.1016\/j.jpainsymman.2023.06.033","volume":"66","author":"J Arthur","year":"2023","unstructured":"Arthur J, Childers J, Del Fabbro E (2023) Should Urine drug screen be done universally or selectively in palliative care patients on opioids? J Pain Symptom Manage 66(6):e687\u2013e692","journal-title":"J Pain Symptom Manage"},{"issue":"1","key":"9622_CR7","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1016\/j.jpainsymman.2024.04.006","volume":"68","author":"M Yusufov","year":"2024","unstructured":"Yusufov M et al (2024) Clinician ordering and management patterns of urine toxicology results at a cancer center. J Pain Symptom Manage 68(1):e36\u2013e45","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"9622_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1634\/theoncologist.2019-0525","volume":"25","author":"JA Arthur","year":"2020","unstructured":"Arthur JA (2020) Urine Drug Testing in Cancer Pain Management. Oncologist 25(2):99\u2013104","journal-title":"Oncologist"},{"issue":"6","key":"9622_CR9","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/cncr.33326","volume":"127","author":"JA Arthur","year":"2021","unstructured":"Arthur JA et al (2021) Random urine drug testing among patients receiving opioid therapy for cancer pain. Cancer 127(6):968\u2013975","journal-title":"Cancer"},{"issue":"9","key":"9622_CR10","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1093\/jnci\/djz233","volume":"112","author":"V Jairam","year":"2020","unstructured":"Jairam V et al (2020) Emergency department visits for opioid overdoses among patients with cancer. J Natl Cancer Inst 112(9):938\u2013943","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"9622_CR11","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1001\/jamaoncol.2019.0042","volume":"5","author":"IS Chua","year":"2019","unstructured":"Chua IS et al (2019) US national trends in opioid-related hospitalizations among patients with cancer. JAMA Oncol 5(5):734\u2013735","journal-title":"JAMA Oncol"},{"key":"9622_CR12","doi-asserted-by":"crossref","unstructured":"Moryl N., et al., Should we use COMM (current opioid misuse measure) to screen for opioid abuse in patients with cancer pain? J Natl Compr Canc Netw, 2023. 21(11): p. 1132\u20131140 e3","DOI":"10.6004\/jnccn.2023.7054"},{"key":"9622_CR13","doi-asserted-by":"crossref","unstructured":"Snyder, M.L., C.R. Fantz, and S. Melanson, Immunoassay-based drug tests are inadequately sensitive for medication compliance monitoring in patients treated for chronic pain. Pain Physician, 2017. 20(2S): p. SE1-SE9","DOI":"10.36076\/sE9"},{"issue":"4","key":"9622_CR14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/jnci\/djaa122","volume":"113","author":"AW Roberts","year":"2021","unstructured":"Roberts AW et al (2021) Opioid use disorder and overdose in older adults with breast, colorectal, or prostate cancer. J Natl Cancer Inst 113(4):425\u2013433","journal-title":"J Natl Cancer Inst"},{"key":"9622_CR15","doi-asserted-by":"crossref","unstructured":"Nabulsi, N.A., et al., Patterns of prescription opioid use and opioid-related harms among adult patients with hematologic malignancies. J Oncol Pharm Pract, 2023: p. 10781552231210788","DOI":"10.1177\/10781552231210788"},{"key":"9622_CR16","doi-asserted-by":"publisher","first-page":"835881","DOI":"10.3389\/fonc.2022.835881","volume":"12","author":"KC Gast","year":"2022","unstructured":"Gast KC et al (2022) Impact of an embedded palliative care clinic on healthcare utilization for patients with a new thoracic malignancy. Front Oncol 12:835881","journal-title":"Front Oncol"},{"issue":"9","key":"9622_CR17","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1200\/OP.22.00454","volume":"19","author":"JL Agne","year":"2023","unstructured":"Agne JL et al (2023) Improving access to early palliative care delivery for patients with an advanced thoracic malignancy through an embedded oncopalliative clinic model. JCO Oncol Pract 19(9):777\u2013785","journal-title":"JCO Oncol Pract"},{"issue":"3","key":"9622_CR18","first-page":"167","volume":"31","author":"EM Bertino","year":"2023","unstructured":"Bertino EM et al (2023) Feasibility of an embedded palliative care clinic model for patients with an advanced thoracic malignancy. Support Care Cancer 31(3):167","journal-title":"Support Care Cancer"},{"issue":"2","key":"9622_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/15360288.2021.1920545","volume":"35","author":"PS Kumar","year":"2021","unstructured":"Kumar PS et al (2021) Substance abuse risk and medication monitoring in patients with advanced lung cancer receiving palliative care. J Pain Palliat Care Pharmacother 35(2):91\u201399","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"7","key":"9622_CR20","doi-asserted-by":"publisher","first-page":"e048801","DOI":"10.1136\/bmjopen-2021-048801","volume":"11","author":"BS Last","year":"2021","unstructured":"Last BS et al (2021) Systematic review of clinician-directed nudges in healthcare contexts. BMJ Open 11(7):e048801","journal-title":"BMJ Open"},{"issue":"1","key":"9622_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13012-020-01072-1","volume":"16","author":"MY Tang","year":"2021","unstructured":"Tang MY et al (2021) How effective are social norms interventions in changing the clinical behaviours of healthcare workers? A systematic review and meta-analysis. Implement Sci 16(1):8","journal-title":"Implement Sci"},{"issue":"2","key":"9622_CR22","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1016\/j.jpainsymman.2024.04.011","volume":"68","author":"SS Kale","year":"2024","unstructured":"Kale SS et al (2024) Creating a palliative care clinic for patients with cancer pain and substance use disorder. J Pain Symptom Manage 68(2):e138\u2013e145","journal-title":"J Pain Symptom Manage"},{"issue":"9","key":"9622_CR23","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1001\/jama.2018.9739","volume":"320","author":"Y Schenker","year":"2018","unstructured":"Schenker Y, Merlin JS, Quill TE (2018) Use of palliative care earlier in the disease course in the context of the opioid epidemic: educational, research, and policy issues. JAMA 320(9):871\u2013872","journal-title":"JAMA"},{"issue":"1","key":"9622_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1177\/1049909121999783","volume":"39","author":"KF Jones","year":"2022","unstructured":"Jones KF et al (2022) Adapting palliative care skills to provide substance use disorder treatment to patients with serious illness. Am J Hosp Palliat Care 39(1):101\u2013107","journal-title":"Am J Hosp Palliat Care"},{"issue":"12","key":"9622_CR25","doi-asserted-by":"publisher","first-page":"e2139968","DOI":"10.1001\/jamanetworkopen.2021.39968","volume":"4","author":"JS Merlin","year":"2021","unstructured":"Merlin JS et al (2021) Expert panel consensus on management of advanced cancer-related pain in individuals with opioid use disorder. JAMA Netw Open 4(12):e2139968","journal-title":"JAMA Netw Open"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09622-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-025-09622-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-025-09622-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T19:32:06Z","timestamp":1757187126000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-025-09622-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["9622"],"URL":"https:\/\/doi.org\/10.1007\/s00520-025-09622-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the institutional review board at The Ohio State University Comprehensive Cancer Center in Columbus, OH, USA. As this was an observational study, the institutional review board confirmed that no ethical approval was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Per the institutional review board, participant consent was not required for this retrospective study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Per the institutional review board, participant consent for publishing was not required as all published data has been de-identified.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"585"}}